401 related articles for article (PubMed ID: 30207609)
1. Pharmacological management of X-linked hypophosphataemia.
Imel EA; White KE
Br J Clin Pharmacol; 2019 Jun; 85(6):1188-1198. PubMed ID: 30207609
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis, treatment-monitoring and follow-up of children and adolescents with X-linked hypophosphatemia (XLH).
Rothenbuhler A; Schnabel D; Högler W; Linglart A
Metabolism; 2020 Feb; 103S():153892. PubMed ID: 30928313
[TBL] [Abstract][Full Text] [Related]
3. A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis.
Insogna KL; Briot K; Imel EA; Kamenický P; Ruppe MD; Portale AA; Weber T; Pitukcheewanont P; Cheong HI; Jan de Beur S; Imanishi Y; Ito N; Lachmann RH; Tanaka H; Perwad F; Zhang L; Chen CY; Theodore-Oklota C; Mealiffe M; San Martin J; Carpenter TO;
J Bone Miner Res; 2018 Aug; 33(8):1383-1393. PubMed ID: 29947083
[TBL] [Abstract][Full Text] [Related]
4. Mutational survey of the PHEX gene in patients with X-linked hypophosphatemic rickets.
Ichikawa S; Traxler EA; Estwick SA; Curry LR; Johnson ML; Sorenson AH; Imel EA; Econs MJ
Bone; 2008 Oct; 43(4):663-6. PubMed ID: 18625346
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of burosumab in children aged 1-4 years with X-linked hypophosphataemia: a multicentre, open-label, phase 2 trial.
Whyte MP; Carpenter TO; Gottesman GS; Mao M; Skrinar A; San Martin J; Imel EA
Lancet Diabetes Endocrinol; 2019 Mar; 7(3):189-199. PubMed ID: 30638856
[TBL] [Abstract][Full Text] [Related]
6. Burosumab: First Global Approval.
Lamb YN
Drugs; 2018 Apr; 78(6):707-714. PubMed ID: 29679282
[TBL] [Abstract][Full Text] [Related]
7. Consensus Recommendations for the Diagnosis and Management of X-Linked Hypophosphatemia in Belgium.
Laurent MR; De Schepper J; Trouet D; Godefroid N; Boros E; Heinrichs C; Bravenboer B; Velkeniers B; Lammens J; Harvengt P; Cavalier E; Kaux JF; Lombet J; De Waele K; Verroken C; van Hoeck K; Mortier GR; Levtchenko E; Vande Walle J
Front Endocrinol (Lausanne); 2021; 12():641543. PubMed ID: 33815294
[TBL] [Abstract][Full Text] [Related]
8. Novel PHEX mutation associated with hypophosphatemic rickets.
Roetzer KM; Varga F; Zwettler E; Nawrot-Wawrzyniak K; Haller J; Forster E; Klaushofer K
Nephron Physiol; 2007; 106(1):p8-12. PubMed ID: 17406123
[TBL] [Abstract][Full Text] [Related]
9. Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia.
Haffner D; Emma F; Eastwood DM; Duplan MB; Bacchetta J; Schnabel D; Wicart P; Bockenhauer D; Santos F; Levtchenko E; Harvengt P; Kirchhoff M; Di Rocco F; Chaussain C; Brandi ML; Savendahl L; Briot K; Kamenicky P; Rejnmark L; Linglart A
Nat Rev Nephrol; 2019 Jul; 15(7):435-455. PubMed ID: 31068690
[TBL] [Abstract][Full Text] [Related]
10. Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial.
Imel EA; Glorieux FH; Whyte MP; Munns CF; Ward LM; Nilsson O; Simmons JH; Padidela R; Namba N; Cheong HI; Pitukcheewanont P; Sochett E; Högler W; Muroya K; Tanaka H; Gottesman GS; Biggin A; Perwad F; Mao M; Chen CY; Skrinar A; San Martin J; Portale AA
Lancet; 2019 Jun; 393(10189):2416-2427. PubMed ID: 31104833
[TBL] [Abstract][Full Text] [Related]
11. Seven novel and six de novo PHEX gene mutations in patients with hypophosphatemic rickets.
Li SS; Gu JM; Yu WJ; He JW; Fu WZ; Zhang ZL
Int J Mol Med; 2016 Dec; 38(6):1703-1714. PubMed ID: 27840894
[TBL] [Abstract][Full Text] [Related]
12. Spectrum of PHEX Mutations and FGF23 Profiles in a Taiwanese Cohort With X-Linked Hypophosphatemia Including 102 Patients.
Su PH; Yu JS; Wu YZ; Tsai YS; Lo FS; Lin JL; Chao MC; Hsu CC; Ke YY; Chiu PC; Chen JC; Huang YH; Lin SP; Chou YY; Ting WH; Wang SY; Chiu CF; Huang YC; Hsiao HP; Lin CH; Wang CH; Bau DT; Lin CY
In Vivo; 2024; 38(1):341-350. PubMed ID: 38148081
[TBL] [Abstract][Full Text] [Related]
13. Mineralized tissues in hypophosphatemic rickets.
Robinson ME; AlQuorain H; Murshed M; Rauch F
Pediatr Nephrol; 2020 Oct; 35(10):1843-1854. PubMed ID: 31392510
[TBL] [Abstract][Full Text] [Related]
14. Clinical practice guidelines for paediatric X-linked hypophosphataemia in the era of burosumab.
Sandy JL; Simm PJ; Biggin A; Rodda CP; Wall CL; Siafarikas A; Munns CF
J Paediatr Child Health; 2022 May; 58(5):762-768. PubMed ID: 35426466
[TBL] [Abstract][Full Text] [Related]
15. Genotype-phenotype analysis, and assessment of the importance of the zinc-binding site in PHEX in Japanese patients with X-linked hypophosphatemic rickets using 3D structure modeling.
Ishihara Y; Ohata Y; Takeyari S; Kitaoka T; Fujiwara M; Nakano Y; Yamamoto K; Yamada C; Yamamoto K; Michigami T; Mabe H; Yamaguchi T; Matsui K; Tamada I; Namba N; Yamamoto A; Etoh J; Kawaguchi A; Kosugi R; Ozono K; Kubota T
Bone; 2021 Dec; 153():116135. PubMed ID: 34333162
[TBL] [Abstract][Full Text] [Related]
16. Validation of a next-generation sequencing (NGS) panel to improve the diagnosis of X-linked hypophosphataemia (XLH) and other genetic disorders of renal phosphate wasting.
Thiele S; Werner R; Stubbe A; Hiort O; Hoeppner W
Eur J Endocrinol; 2020 Nov; 183(5):497-504. PubMed ID: 33107440
[TBL] [Abstract][Full Text] [Related]
17. X-linked hypophosphatemia and burosumab: Practical clinical points from the French experience.
Bacchetta J; Rothenbuhler A; Gueorguieva I; Kamenicky P; Salles JP; Briot K; Linglart A
Joint Bone Spine; 2021 Oct; 88(5):105208. PubMed ID: 34102329
[TBL] [Abstract][Full Text] [Related]
18. High iFGF23 level despite hypophosphatemia is one of the clinical indicators to make diagnosis of XLH.
Igaki JM; Yamada M; Yamazaki Y; Koto S; Izawa M; Ariyasu D; Suzuki E; Hasegawa H; Hasegawa Y
Endocr J; 2011; 58(8):647-55. PubMed ID: 21597229
[TBL] [Abstract][Full Text] [Related]
19. Outcome of adult patients with X-linked hypophosphatemia caused by PHEX gene mutations.
Chesher D; Oddy M; Darbar U; Sayal P; Casey A; Ryan A; Sechi A; Simister C; Waters A; Wedatilake Y; Lachmann RH; Murphy E
J Inherit Metab Dis; 2018 Sep; 41(5):865-876. PubMed ID: 29460029
[TBL] [Abstract][Full Text] [Related]
20. A mosaic mutation of phosphate-regulating gene with homologies to endopeptidases on the X chromosome (PHEX) in X-linked hypophosphatemic rickets with mild bone phenotypes.
Asano S; Sako S; Funasaki Y; Takeshita Y; Niida Y; Takamura T
Endocr J; 2021 Sep; 68(9):1135-1141. PubMed ID: 33907069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
